| Wilberforce Tamaklo, MD | |
|
800 N Fant St, Anderson, SC 29621-5708 | |
| (864) 512-1810 | |
| (864) 512-1805 |
| Full Name | Wilberforce Tamaklo |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 800 N Fant St, Anderson, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811005192 | NPI | - | NPPES |
| 276962 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 27696 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wilberforce Tamaklo, MD 109 Essex Dr, Anderson, SC 29621-3318 Ph: (864) 512-3879 | Wilberforce Tamaklo, MD 800 N Fant St, Anderson, SC 29621-5708 Ph: (864) 512-1810 |
News Archive
Getting a better grip on things: The MoreGrasp Horizon2020 research project under the leadership of TU Graz is coming to an end with significant results in the field of thought-controlled grasp neuroprosthetics.
For more than three decades, researchers have warned of the potential health risks associated with exposure to environmental tobacco smoke (ETS), especially among children whose parents smoke. Now a new study conducted by researchers from the University of Arizona reports that those health risks persist well beyond childhood, independent of whether or not those individuals end up becoming smokers later in life.
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
A study published in the September 2014 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that children and adolescents diagnosed with a psychiatric diagnosis had an increased risk of developing diabetes if they were exposed to antipsychotics.
With the increasing number of infections across the globe, scientists have resorted to studying existing drugs in the hope of discovering a cure for the coronavirus disease (COVID-19). A team of researchers has found that an existing drug, Nafamostat or Fusan, a drug used to treat acute pancreatitis, may effectively block the process used by the novel coronavirus to spread and cause illness.
› Verified 9 days ago
Urvi Shah, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Highway 252, Anderson, SC 29621 Phone: 864-231-2600 | |
Abdalla Bamashmus, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1810 Fax: 864-512-1805 | |
Joseph M Mcelwee, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 3700, Anderson, SC 29621 Phone: 864-512-1475 Fax: 864-512-1930 | |
John H Purcell, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 130 Hwy 252, Anderson, SC 29622 Phone: 803-898-8405 | |
Sam Harry Ross, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 130 Highway 252, Anderson, SC 29621 Phone: 803-898-8405 | |
Dr. Violeta Nistor, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Sc-252, Anderson, SC 29621 Phone: 864-231-2600 | |
Raymond Kimball, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 130 Highway 252, Anderson, SC 29621 Phone: 803-898-8405 |